1. Home
  2. LCNB vs NBTX Comparison

LCNB vs NBTX Comparison

Compare LCNB & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LCNB Corporation

LCNB

LCNB Corporation

HOLD

Current Price

$17.27

Market Cap

205.5M

Sector

Finance

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$22.91

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCNB
NBTX
Founded
1877
2003
Country
United States
France
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.5M
1.0B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
LCNB
NBTX
Price
$17.27
$22.91
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
24.1K
49.9K
Earning Date
01-29-2026
09-30-2025
Dividend Yield
5.09%
N/A
EPS Growth
220.73
N/A
EPS
1.67
N/A
Revenue
$89,312,000.00
$11,930,711.00
Revenue This Year
$18.04
N/A
Revenue Next Year
$4.36
$136.64
P/E Ratio
$10.36
N/A
Revenue Growth
19.58
N/A
52 Week Low
$13.34
$2.82
52 Week High
$17.50
$30.35

Technical Indicators

Market Signals
Indicator
LCNB
NBTX
Relative Strength Index (RSI) 74.50 57.57
Support Level $15.97 $20.83
Resistance Level $16.18 $23.77
Average True Range (ATR) 0.35 0.88
MACD 0.15 0.17
Stochastic Oscillator 89.32 77.16

Price Performance

Historical Comparison
LCNB
NBTX

About LCNB LCNB Corporation

LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: